1. Home
  2. CTXR vs LMFA Comparison

CTXR vs LMFA Comparison

Compare CTXR & LMFA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTXR
  • LMFA
  • Stock Information
  • Founded
  • CTXR 2007
  • LMFA 2008
  • Country
  • CTXR United States
  • LMFA United States
  • Employees
  • CTXR N/A
  • LMFA N/A
  • Industry
  • CTXR Biotechnology: Pharmaceutical Preparations
  • LMFA Finance: Consumer Services
  • Sector
  • CTXR Health Care
  • LMFA Finance
  • Exchange
  • CTXR Nasdaq
  • LMFA Nasdaq
  • Market Cap
  • CTXR 23.0M
  • LMFA 11.9M
  • IPO Year
  • CTXR N/A
  • LMFA 2015
  • Fundamental
  • Price
  • CTXR $1.33
  • LMFA $1.25
  • Analyst Decision
  • CTXR Strong Buy
  • LMFA Strong Buy
  • Analyst Count
  • CTXR 3
  • LMFA 1
  • Target Price
  • CTXR $53.00
  • LMFA $5.00
  • AVG Volume (30 Days)
  • CTXR 443.9K
  • LMFA 544.2K
  • Earning Date
  • CTXR 08-12-2025
  • LMFA 08-14-2025
  • Dividend Yield
  • CTXR N/A
  • LMFA N/A
  • EPS Growth
  • CTXR N/A
  • LMFA N/A
  • EPS
  • CTXR N/A
  • LMFA N/A
  • Revenue
  • CTXR N/A
  • LMFA $6,755,925.00
  • Revenue This Year
  • CTXR N/A
  • LMFA N/A
  • Revenue Next Year
  • CTXR $851.67
  • LMFA $6.50
  • P/E Ratio
  • CTXR N/A
  • LMFA N/A
  • Revenue Growth
  • CTXR N/A
  • LMFA N/A
  • 52 Week Low
  • CTXR $0.65
  • LMFA $1.02
  • 52 Week High
  • CTXR $15.25
  • LMFA $5.14
  • Technical
  • Relative Strength Index (RSI)
  • CTXR 48.91
  • LMFA 34.67
  • Support Level
  • CTXR $1.23
  • LMFA $1.25
  • Resistance Level
  • CTXR $1.43
  • LMFA $1.34
  • Average True Range (ATR)
  • CTXR 0.11
  • LMFA 0.16
  • MACD
  • CTXR 0.01
  • LMFA -0.07
  • Stochastic Oscillator
  • CTXR 38.46
  • LMFA 1.32

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.

About LMFA LM Funding America Inc.

LM Funding America Inc is a financial services company. The company provides funding to nonprofit community associations located in the state of Florida and to nonprofit community associations in the states of Washington and Colorado. Its products include Original Product and New Neighbor Guaranty. Its original product offering consists of providing funding to Associations by purchasing their rights under delinquent accounts that are selected by the Associations arising from unpaid Association assessments. It currently has two lines of business recently commenced cryptocurrency mining business and historical specialty finance business. The Company has two operating segments: Specialty Finance and Mining Operations, which generate the majority of its revenue.

Share on Social Networks: